ask="3.50"
ask_size="6000"
average_daily_volume="226110"
bid="3.00"
bid_size="400"
book_value="0.07"
change="-0.10"
change_from_200_day_moving_average="-0.14"
change_from_50_day_moving_average="0.28"
change_from_52_week_high="-1.50"
change_From_52_week_low="0.60"
change_in_percent="-3.23%"
close="3.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.98"
ebitda="-30.33M"
eps_estimate_current_year="-0.98"
eps_estimate_next_quarter="-0.27"
eps_estimate_next_year="-1.10"
ex_dividend_date="N/A"
float_shares="26690000"
high="3.15"
high_52_weeks="4.50"
last_trade_date="2/7/2017"
last_trade_price="3.00"
last_trade_size="2846"
last_trade_time="4:00pm"
low="3.00"
low_52_weeks="2.40"
market_capitalization="136.00M"
moving_average_200_day="3.14"
moving_average_50_day="2.72"
name="AcelRx Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.80"
open="3.10"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-4.39%"
percent_change_from_50_day_moving_average="+10.37%"
percent_change_from_52_week_high="-33.33%"
percent_change_from_52_week_low="+25.00%"
previous_close="3.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="43.06"
price_per_sales="11.11"
revenue="12.65M"
shares_outstanding="45333000"
short_ratio="14.06"
stock_exchange="NGM"
symbol="ACRX"
volume="216331"
weeks_range_52="2.40 - 4.50"
